New Periodontitis Treatment Based on Hyaluronic Acid and Melatonin

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions
Chronic Periodontitis
Interventions
DRUG

Tetracycline-Metronidazole (TM) group

Following mechanical debridement (scaling and root planning) the above-mentioned paste will be topically administrated in the periodontal pocket of affected teeth once a day, for 30 consecutive days.

DRUG

TM-Melatonin-Hyaluronic acid (TM-MHa) group

Following mechanical debridement (scaling and root planning) the above-mentioned paste will be topically administrated in the periodontal pocket of affected teeth once a day, for 30 consecutive days.

Trial Locations (2)

041335

Concordia Dent Clinic, Bucharest

Unknown

"Carol DavilaUniversity of Medicine and Pharmacy", Bucharest

All Listed Sponsors
collaborator

Carol Davila University of Medicine and Pharmacy

OTHER

collaborator

Romanian National Authority for Scientific Research and Innovation (UEFISCIDI)

UNKNOWN

collaborator

University Politechnica of Bucharest

UNKNOWN

collaborator

TURKEY MEDISEN Ltd

UNKNOWN

lead

Concordia Dent Srl

OTHER

NCT03656484 - New Periodontitis Treatment Based on Hyaluronic Acid and Melatonin | Biotech Hunter | Biotech Hunter